Quantitative Micro-CT Analysis of Aortopathy in a Mouse Model of β-aminopropionitrile-induced Aortic Aneurysm and Dissection
July 16th, 2018
8.8K views
This article describes a detailed methodology of using a radiopaque lead-based silicone rubber to perfuse the murine vasculature for aortic diameter quantification in a mouse model of aortic aneurysm and dissection.
Overview
This article describes a detailed methodology of using a radiopaque lead-based silicone rubber to perfuse the murine vasculature for aortic diameter quantification in a mouse model of aortic aneurysm and dissection. This method could help answer key questions in the vascular biology field, particularly regarding vessel size in different animal models of vascular disease.
Key Study Components
Area of Science
- Vascular biology
- Mouse models
- Aortic aneurysm and dissection
Background
- Understanding vessel size is crucial in vascular disease research.
- Micro-CT provides detailed imaging of both large and small vessels.
- The technique allows for precise quantification of vascular structures.
- Preparation involves surgical procedures for postmortem analysis.
Purpose of Study
- To quantify aortic diameter in a mouse model.
- To assess the impact of vascular disease on vessel size.
- To utilize advanced imaging techniques for better analysis.
Methods Used
- Use of radiopaque lead-based silicone rubber for perfusion.
- Micro-CT imaging for detailed vascular analysis.
- Intracardiac perfusion postmortem for specimen preparation.
- Administration of isoflurane for anesthesia during procedures.
Main Results
- Detailed imaging of murine vasculature achieved.
- Quantification of aortic diameter demonstrated.
- Methodology validated for use in vascular biology studies.
- Potential applications in understanding vascular diseases.
Conclusions
- The technique enhances the ability to study vascular changes.
- Micro-CT imaging is effective for both large and small vessels.
- This methodology can inform future research in vascular biology.
Frequently Asked Questions
What is the main advantage of this technique?
The main advantage is that micro-CT enables detailed images of both large and small vessels, allowing for precise quantification.
How is anesthesia maintained during the procedure?
Anesthesia is maintained with 2 to 2.5 percent isoflurane from a face mask attached to a scavenger with one liter of oxygen per minute.
What preparations are needed before the CT analysis?
Surgical procedures must be performed 24 hours prior to the CT analysis to prepare the specimen for postmortem intracardiac perfusion.
What is the purpose of the toe pinch test?
The toe pinch test is performed to check for the absence of a pedal reflex, ensuring the animal is adequately anesthetized.
What type of imaging does this method utilize?
This method utilizes micro-CT imaging to provide detailed images of the vasculature.
In what context can this methodology be applied?
This methodology can be applied in studies related to vascular diseases and the quantification of vessel size in various animal models.
Executive Industry Relevance
Quantitative micro-CT analysis of aortopathy in mouse models enables precise, reproducible measurement of vascular pathology, supporting early-stage target validation and mechanistic de-risking in cardiovascular drug discovery. This imaging-driven workflow enhances predictive confidence for translational research by providing standardized, quantitative endpoints for aortic aneurysm and dissection models. The approach is positioned to inform portfolio triage and risk-adjusted advancement decisions in preclinical vascular biology programs.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables quantitative assessment of vascular remodeling and disease progression in genetically or chemically induced models.
- Supports mechanistic de-risking by correlating vessel size changes with molecular interventions.
- Provides standardized criteria for defining aneurysm thresholds, improving target validation rigor.
Screening & Assay Development
- Facilitates preparation of validated vascular models for downstream imaging-based screening.
- Delivers reproducible, quantitative vessel diameter measurements for assay standardization.
- Enables cross-study comparison and scalability for compound evaluation in vascular disease models.
Translational & Preclinical Research
- Aligns preclinical endpoints with clinically relevant vascular pathology, supporting translational biomarker strategies.
- Provides continuity from discovery through preclinical validation by enabling robust, quantitative imaging outputs.
- Reduces biological ambiguity in preclinical decision-making for aortic disease programs.
Pipeline & Workflow Integration
This micro-CT imaging protocol integrates into the discovery-to-preclinical continuum, bridging early mechanistic studies with translational model validation for aortic disease research.
- Discovery Biology: Supports hypothesis testing on vascular remodeling and disease mechanisms in mouse models.
- Screening: Provides quantitative, reproducible vessel measurements for assay readiness and cross-study comparability.
- Analytics: Enables statistical analysis of aortic diameters and aneurysm frequency across experimental groups.
- Translational Research: Aligns preclinical imaging outputs with clinical vascular endpoints for biomarker development.
- Enterprise Reuse: Establishes a standardized imaging workflow adaptable to other vascular beds and disease models.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in vascular target validation.
- Operational Value: Delivers standardized, reproducible, and scalable imaging protocols for cross-team adoption.
- Strategic Value: Improves go/no-go decisions and capital efficiency by providing robust quantitative endpoints.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of vascular disease programs.
Implementation Considerations
- Requires expertise in animal surgery, vascular perfusion, and micro-CT imaging analysis.
- Demands access to micro-CT instrumentation and radiopaque contrast agents.
- Necessitates rigorous cross-team standardization of imaging and measurement protocols.
- Adaptable to various vascular beds and disease models with protocol optimization.
- Non-survivability of the procedure limits longitudinal studies in the same animal.
Biopharma FAQs
Why does null hypothesis testing matter for aortic diameter quantification?
Null hypothesis testing enables objective assessment of whether observed differences in aortic diameter between treated and control groups are statistically significant, supporting rigorous target validation and mechanistic de-risking in vascular disease models.
How does independent variable isolation fit the micro-CT workflow?
Isolating variables such as BAPN treatment ensures that changes in vessel size and aneurysm frequency measured by micro-CT can be attributed to specific interventions, strengthening the interpretability of preclinical findings.
What do quantitative dependent variable measurements enable in this protocol?
Quantitative measurements of aortic diameter and aneurysm incidence provide standardized, reproducible endpoints for comparing disease progression and therapeutic effects across experimental groups, facilitating data-driven decision-making.
Why are replication requirements critical for cross-functional vascular studies?
Replication with blinded observers and standardized measurement criteria ensures reproducibility and reliability of micro-CT data, enabling cross-functional teams to confidently compare results and advance promising targets.
What statistical analysis capabilities are required before implementing micro-CT quantification?
Robust statistical analysis, including threshold-based aneurysm definition and group comparisons, is essential to validate findings and support translational continuity from preclinical imaging to clinical biomarker development.
